Methylene Blue-Stained Single-Stranded DNA Aptamers as a Highly Efficient Electronic Switch for Quasi-Reagentless Exosomes Detection: An Old Dog with New Tricks

被引:5
|
作者
Wang, Yanhong [1 ]
Jie, Han [1 ]
Ye, Huajuan [1 ]
Zhang, Yuanyuan [1 ]
Li, Ning [1 ,2 ]
Zhuang, Junyang [1 ,2 ]
机构
[1] Fujian Med Univ, Sch Pharm, Higher Educ Key Lab Nano Biomed Technol Fujian Pro, Fuzhou 350122, Peoples R China
[2] Fujian Med Univ, Fujian Key Lab Drug Target Discovery & Struct & Fu, Fuzhou 350122, Peoples R China
基金
中国国家自然科学基金;
关键词
ELECTROCHEMICAL INDICATOR; BINDING; SENSOR;
D O I
10.1021/acs.analchem.3c03715
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Improving the convenience, sensitivity, and cost-effectiveness of electrochemical biosensors is crucial for advancing their clinical diagnostic applications. Herein, we presented an elegant approach to construct electrochemical aptasensors for tumor-derived exosome detection by harnessing the alterable interaction between methylene blue (MB) and DNA aptamer. In detail, the anti-EpCAM aptamer, named SYL3C, was found to exhibit a strong affinity toward MB due to the specific interaction between MB and unbound guanine bases. Thereby, SYL3C could be stained with MB to arouse a strong electrochemical signal on a gold electrode (AuE). Upon binding to EpCAM-positive exosomes, SYL3C underwent a conformational transformation. The resulting conformation, or exosomes-SYL3C complex, not only reduced the accumulation of MB on SYL3C by obstructing the accessibility of guanines to MB but also impeded the transfer of electrons from the bound MB to AuE, leading to a notable decrease in the electrochemical signal. Using MB-stained SYL3C as an electronic switch, an electrochemical aptasensor was readily established for the detection of EpCAM-positive exosome detection. Without the need for signal amplification strategies, expensive auxiliary reagents, and complex operation, this unique signal transduction mechanism alone could endow the aptasensor with ultrahigh sensitivity. A limit of detection (LOD) of 234 particles mL(-1) was achieved, surpassing the performance of most reported methods. As a proof of concept, the aptasensor was applied to analyze clinical serum samples and effectively distinguish non-small-cell lung cancer (NSCLC) patients from healthy individuals. As EpCAM exhibits broad expression in exosomes derived from different tumor sources, the developed aptasensor holds promise for diagnosing other tumor types.
引用
收藏
页码:18166 / 18173
页数:8
相关论文
empty
未找到相关数据